Skip to content
PeptideSport

Evidence review

Peptide Injections for Weight Loss: What's in the Vial (2026)

Which weight-loss peptide injections have real trial data, how approved and compounded and gray-market vials differ, and what testing found inside them.

Written by Derek OlssonSports Science Editor

Search "peptide injections for weight loss" and you will be shown three completely different products under one label: an FDA-approved prescription medicine, a compounded copy of that medicine prepared by a pharmacy, and an unregulated vial mailed from a website with "for research use only" on the box. They can contain nominally the same molecule. They are not the same purchase, and the differences are not paperwork — laboratory analyzes have measured what actually arrives at the door.

The short version: the injectable weight-loss peptides with real evidence are the incretin drugs, and the evidence attaches to the approved product tested in the trial, not to the molecule in the abstract. How you obtain it determines whether any of that evidence transfers. That is the argument of this page.

The three tiers, and why the distinction is the whole story

Tier one: FDA-approved incretin drugs. Semaglutide and tirzepatide are approved, manufactured under pharmaceutical quality systems, and carry the trial data everyone quotes. In STEP 1, 1,961 adults randomized to once-weekly semaglutide 2.4 mg or placebo for 68 weeks saw mean body-weight change of −14.9% versus −2.4%1. In SURMOUNT-1, 2,539 adults on tirzepatide reached −15.0%, −19.5% and −20.9% at 5, 10 and 15 mg against −3.1% for placebo2. The investigational triple agonist retatrutide reached −24.2% at 48 weeks in phase 2, and remains unapproved3. Buying the approved drug through a telehealth platform can still separate the headline number from the real one: Wisp's "$99/month" is the consult fee for its brand-name Wegovy, Zepbound and Saxenda path — the medication itself is billed separately at pharmacy pickup or checkout, and brand-name GLP-1s commonly list well above $1,000/month without insurance. That distinction between the approved-drug and compounded tiers can hide inside one storefront's own pricing, too: Kin Meds' advertised "$149/month" headline turns out to be the brand-name (Wegovy/Zepbound/Foundayo) entry price, not the compounded medication most readers expect — compounded semaglutide there actually starts at $199/month. The largest brand-name-only channels run their own version of the same gap: Amazon One Medical's "$1/day" Foundayo headline requires both insurance and a manufacturer coupon — without them, the real cash-pay rate is $149/month, Ro's $149/mo Foundayo figure is the drug price alone, with a recurring membership billed separately on top of it, GoodRx is a discount card rather than a prescriber, so its self-pay figures only apply once a separate clinician has already written the prescription, and LillyDirect's cheapest advertised rate, $25/month, is closed to Medicare and Medicaid patients entirely.

Tier two: compounded versions. A licensed compounding pharmacy prepares the drug against a prescription. There is a real prescriber and a licensed pharmacy in the chain, which matters — though how much of that chain you are allowed to see varies enormously, and Enhance MD naming three LegitScript-certified compounding pharmacies and the 40 states plus DC it serves puts it in a small minority; most sellers name no facility at all — Center for Medical Weight Loss and Coivas both cite only a pharmacy category, "LegitScript-certified" and "503A/503B, NABP-accredited" respectively, with no facility named, NP2GO takes the opposite approach on price while doing the same on pharmacy — a full per-dose pricing matrix published openly, with no compounding pharmacy named anywhere on the site, though Coivas does at least name the clinical practice behind the prescribing, Arora Health & Aesthetics, LLC, with a named medical director. Precision Telemed names none of its own but states every shipment includes a Certificate of Analysis confirming potency and purity, a checkable claim of a different kind. MediRX names its clinical and pharmacy backbone one level up — OpenLoop Health's licensed network — without naming the specific compounding facility within it, and Heva Health names neither a pharmacy nor a legal entity behind its otherwise distinctive 91-biomarker lab panel. LeanDose describes its own pharmacy only as "FDA-registered," a category claim rather than a name. At the deep end of naming, Ondra Health names five prescribing physicians and five 503A pharmacy partners by name, though one of those five is excluded from nine specific states despite an advertised all-50-states banner — real depth with a real carve-out underneath it. MedLeanRx and Nalena sit at opposite ends of the same question: MedLeanRx names a supervising physician but no pharmacy, while Nalena names neither a pharmacy nor a consistent clinical-provider name across captures. But state it plainly, because a lot of marketing does not: compounded semaglutide and tirzepatide are not FDA-approved products. They have not been through the agency's review of safety, efficacy or manufacturing for that specific preparation. The trial results above were generated with the approved product, and they do not automatically carry over to a different preparation at a different concentration from a different facility. Sometimes the molecule itself is not committed to in writing: SHED's semaglutide marketing leads to a generic "GLP-1 Injections" product whose own description says the best option will be determined, listing semaglutide as one possibility rather than a guarantee. Factor Health MD does the opposite, naming semaglutide, tirzepatide and the less commonly offered liraglutide as three distinct, separately priced products rather than one interchangeable "GLP-1" line. Openness about price is not the same as openness about the chain: Bliv prints compounded semaglutide from $116 a month on its public pricing page, then describes the pharmacy filling it only as an "FDA-regulated pharmacy in the U.S." — naming neither the facility nor whether it is a 503A compounder or a 503B outsourcing facility. At the better end, Primary Clinic states outright that its members' compounded tirzepatide and semaglutide come from "licensed 503A pharmacies" at wholesale pricing — the category, at least, in writing, and Ozari Health makes the same category claim, "503A and 503B compounding," without naming a single facility either. NuuVim goes a step further and names two specific facilities, Hallandale Pharmacy and Pharmacy Hub, rather than a category alone, Tyde Wellness names five at once — Belmar, Casa, Olympia, Red Rock and Beaker, each with a city and state attached, and Zera Health names one, Strive Pharmacy, while also disclosing plainly that its compounded GLP-1s are not FDA-approved. Coby Health names its clinical network, Beluga Health P.A., but stops short of naming the pharmacy that actually fills the prescription, and Injectco, a Dallas medspa selling GLP-1 alongside Botox and fillers, never specifies which drug — semaglutide or tirzepatide — its bulk price actually covers. Unique Physique goes a step further still: neither its pricing page nor its service page states which GLP-1 molecule either of its two flat-rate plans actually contains, a gap only a phone call resolves. Contour Health names its pharmacy outright, Strive Pharmacy, 503A accredited, while NexLife commits to a pharmacy standard — LegitScript-certified, NABP-accredited — without naming an individual facility, per prior research this pass's blocked fetch could not reconfirm, and Rejuve Meds names only a self-branded "Pharmacy Network," a category label rather than a checkable facility. MyFastRx and Actin both stop at a generic category too — "state-licensed pharmacies" and no mention at all, respectively, the same shape Actin's own pricing page shows. FormidableMD names the category, 503A, without naming a specific facility, while Alloy names none at all despite running the broadest formulary here. PeptidesRx, positioned explicitly against gray-market sellers, doesn't name its own pharmacy either — a reminder that "compliance-focused" branding and pharmacy transparency are two different claims. and LevelUp Rx names two, DiRx and The DrugStore, though its sales are final once shipped, with no returns on dispensed medication. PCOS Sisters names two more, Strive and Striker, on a page built specifically around PCOS rather than general weight loss. and Revel RX does the same — Manifest Pharmacy and Red Rock Home Pharmacy, both named as 503A/503B facilities. Potere Health MD names its pharmacy too — Kaduceus — on a dedicated page that also explains what a certificate of analysis does and does not prove, and boostAGErx goes furthest of all, publishing Manifest Pharmacy's full street address rather than just a name. At the other, OurView Health says on one screen that its parent company is a nationwide pharmacy compounding the drug itself and on another that it partners with a licensed pharmacy, which are two different businesses with two different lines of accountability. Some sellers skip naming a pharmacy at all: Loop Health bills compounded GLP-1 through an unnamed "independent" pharmacy, with no 503A or 503B designation stated anywhere on the site, and Embody's storefront prices two compounded products in detail without naming who compounds either one. TRYM Health goes a step further and says outright that it "does not directly provide medical or pharmacy services" itself — a subscription platform sitting in front of an unnamed clinical and pharmacy chain. Candor Rx sits at the opposite extreme without saying so on its marketing pages: its own returns policy names the pharmacy as "Vigor Compounding LLC DBA Candor Rx/Manifest Pharmacy" — the storefront and the compounder are the same legal entity. FormBlends doesn't even complete checkout on its own domain — the marketing site hands off to a separate portal, rx.formscripts.com, for the actual intake and purchase, and its refund terms live in whatever document that portal shows you, not on the page you'd check first. Southern Vitality and Weight Loss, operating since 2012, names two pharmacies by name in its own materials — PerfectRx and Pharmacy Hub, the kind of specific, checkable disclosure most of this category still skips. Teleios Health names four — Strive Pharmacy, Epiq Scripts, Casa Pharma Rx and The Pharmacy Hub — each with a phone number and a website, the deepest pharmacy disclosure found here so far. That naming also reveals something the marketing rarely says out loud: VitaraRx names Manifest Pharmacy in Greer, SC — the identical facility and address that boostAGErx and Candor Rx also name, three differently-branded storefronts running on one compounding pharmacy behind the scenes. Cora Health names VialsRx as one of its two pharmacy partners, and Curve names the identical VialsRx too, confirmed live on this pass — a fourth pair sharing one dispensing pharmacy behind two different brands, and Curve's own logo file is internally named "CurbHealth," not Curve, a rebrand leftover in the site's own code. Healthicare names both its clinical partner and dispensing pharmacy outright — Beluga Health and Jungle Jim's Pharmacy, both confirmed live on this pass, naming the same Beluga Health network documented elsewhere on this site. ElixaMD names two pharmacies of its own, RedRock and Beaker, real transparency, though its $179 headline is a first-month price only. eMI Aesthetics names neither a pharmacy nor a medical director, routing intake through OpenLoop Health instead and showing no per-drug price until after intake. YourHealthRx claims "transparent sourcing" too, but names no compounding pharmacy at all — a claim without the disclosure to back it up. Carocare Wellness names no pharmacy at all — a genuine Houston clinic, but one with no published clinical-oversight detail behind its in-person visits. FitFlow and Genesis Health both name no pharmacy beyond a generic "licensed" claim, on top of pricing structures where the lowest advertised figure requires a full year prepaid, a pattern Genesis Health repeats almost exactly. Nova MD stops at "accredited facilities" too, despite otherwise publishing all four of its SKU prices openly. Belle Health names four separate pharmacy partners across its policy pages — BPI Labs, VitalRx Pharmacy, The Pharmacy Hub, and Olympia Pharmaceuticals — matching Teleios Health's depth of disclosure, which sits oddly next to an FDA warning letter it received in February 2026 for the opposite failure on its actual product pages: labeling compounded drugs with Belle's own name in a way regulators read as claiming Belle was the compounder. Naming your pharmacy in the fine print doesn't offset branding the product itself as your own. Not every claim holds up on a second look, though: an earlier capture of Framework's row recorded a named 503B pharmacy partner, but this pass could not find that name anywhere in the site's fetchable content — including its own FAQ, which poses the question "What pharmacies does Framework work with?" without rendering an answer — a reminder that a disclosure confirmed once still needs re-checking on every pass. Woodwork's terms of service name five separate pharmacy partners — Precision Compounding Pharmacy, TriadRX, RedRock Pharmacy, Beaker Pharmacy, and Link Pharmacy, the deepest single-provider disclosure found on this list yet, and Next Meds names six — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub, and Foothills matches it. Big Easy Weight Loss names six of its own — Seven Cells, Hallandale, OptioRx, Miller's, ProRx/PerfectRx, and BPI/Vita, a third provider at that same depth. Piper, now operating as Polly, names two pharmacy partners in its refund policy — Hallandale Pharmacy and VialsRx. A marketplace works the naming question differently: Lavender Sky operates as a marketplace where patients choose from an unpublished list of partner pharmacies after enrollment, rather than a single named facility upfront, a structural reason no single pharmacy gets named on the page. A named physician doesn't always come with a named pharmacy: Florida Weight Loss MD is led by a real, credentialed physician, Dr. Sergey Terushkin, MD, FACS, but names no compounding pharmacy anywhere on the site, and doesn't publish monthly medication pricing either, and June Health publishes a full per-dose price list for both injectable and oral compounded semaglutide and tirzepatide, yet names no pharmacy, medical group, or legal entity behind any of it — a newer domain with the opposite disclosure gap from Florida Weight Loss MD's single-clinic model. DoctorAdam names two, Olympia Pharmaceuticals and Carie Boyd Pharmaceuticals, a rarer level of specificity, per prior research not independently reconfirmed after the site was rate-limited on every fetch attempt this pass, while Ivologist's own Terms of Service — the deepest page this pass could check — never names a pharmacy at all. Brand-name channels sidestep the naming question in a different way: 9amHealth prescribes FDA-approved branded GLP-1s through standard retail pharmacy channels rather than a named compounder, but gates access behind insurance coverage and BMI criteria the site doesn't enumerate upfront. A similar insurance-first structure shows up again at larger scale: Found Health names no compounding pharmacy anywhere on its own site, dispensing both compounded and branded GLP-1s through an insurance-integrated program rather than a single named compounder. Harper Meds names no pharmacy at all, per prior research, on a site that bundles the consult, prescription, medication and shipping into one flat monthly price. And a named clinical network is not the same as a named pharmacy: Silhouette MD routes prescriptions through OpenLoop Health, a real, established telehealth network already documented behind other reviews on this site, without naming the compounding facility that actually fills them. At the deeper end of naming, Raeliva (formerly OnlineSemaglutide.org) names all four compounding pharmacies in its network outright — Casa, Polomar, Perfectrx, and Evoluciona — confirmed live, one of the more thorough disclosures found on this list, while SynergenX Health, a 64-clinic hormone and weight-loss chain, names no specific compounding pharmacy behind its telehealth GLP-1 program. Medivive names no pharmacy at all, per prior research, on a site that discloses its price only after an AI-guided intake, and GobyMeds describes its own pharmacy only as a "503A or 503B pharmacy partner, licensed in your state," confirmed live, without naming a specific facility. ReadyRx pairs a working LegitScript verification link with a pharmacy description that stays generic — "FDA-registered compounding pharmacies," plural, confirmed live — never naming a specific facility. Roboclinic routes fulfillment through OpenLoop Health, an established clinical network, rather than an individually named pharmacy, per prior research, and Vaylen names neither a compounding pharmacy nor its clinical leadership despite a working, domain-specific LegitScript link, confirmed live. VyrarX displays a LegitScript seal but names no compounding pharmacy on any public page, confirmed live. YOURx Health names no pharmacy at all, and its own homepage coverage counter still reads "0 States," confirmed live, while Vytora Health names two, Vials Pharmacy and Hallandale Pharmacy, each with a full street address, confirmed live. Elara Health and Wellness goes further still, naming four separate 503A pharmacies — RedRock, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx — confirmed live, among the deepest disclosures found here. DreamHug Medical names no compounding pharmacy anywhere, confirmed live, on a homepage that also displays an "FDA-approved" badge for a product that isn't, while Bionomy Health names two, Strive Pharmacy and Absolute Pharmacy, confirmed live via its own footer. VitaFusions IV describes its medication as "compounded in our pharmacy," an in-house claim rather than a named external facility, confirmed live, while Somira Health names four — Jungle Jim's Pharmacy, GoGoMeds, The Pharmacy Hub LLC, and VialsRX — each with a full street address, confirmed live, an update on prior research that had found none named. Eve names no compounding pharmacy anywhere in the sources this pass could read. MaxLife's membership price bundles supplies and priority shipping, confirmed live, but names no compounding pharmacy anywhere, and Lumen Meds includes free expedited cold shipping — a genuinely important detail for GLP-1 cold-chain integrity — while also leaving its pharmacy unnamed. Aurelius Health Group is candid, confirmed live, that its microdose protocol delivers less than "full dose pen programs" — but still names no compounding pharmacy, describing it only as "licensed US compounding pharmacies". Neither AMP Health nor Ascend Vitality names a compounding pharmacy either — AMP Health's site is currently down entirely, while Ascend Vitality's registered address matches three other differently-branded storefronts already documented on this site. Curex names no compounding pharmacy despite a real, checkable legal entity and office address, confirmed live, and DrBrainRx uses USP-certified 503B pharmacies, per prior research, though none is individually named. Get Thin MD names four pharmacies with full addresses, confirmed live — three of which are the identical facilities already named by Elara Health and Wellness, while Go Vida Plena names no compounding pharmacy anywhere in the sources this pass could find.

Tier three: "research use only" vials sold online without a prescription. No prescriber, no pharmacy, no dispensing standard, and no obligation to make what the label claims. This is where the measured data gets ugly.

Three products, one search term

FDA-approvedCompounded Rx'Research use only' vial
Prescriber involvedYesYesNo
Licensed pharmacyYesYesNo
FDA-reviewed for safety and efficacyYesNoNo
Is the trial evidence for this productYesNo — a different preparationNo
Measured purity in published analyzesPharmaceutical specVaries by facility7.7%–14.37% vs 99% claimed
Endotoxin found in tested samplesAll samples, 2.16–8.95 EU/mg
Accountable party if something goes wrongManufacturerPrescriber + pharmacyNone
The trial data belongs to the first column. Whether any of it transfers to the other two is the question the marketing never asks.

What testing actually found inside gray-market vials

This is not a hypothetical risk, and it is worth going through the numbers rather than gesturing at "quality concerns."

A 2024 market-surveillance study published in the Journal of Medical Internet Research did the rare thing: it bought the product. Researchers screened 1,080 search-result links, identified 317 belonging to online pharmacies of which 183 were illegal, and made test purchases from six illegal online pharmacies offering semaglutide without prescription at the lowest prices. Three prefilled-pen orders never arrived at all — straightforward e-commerce fraud. Three vials were delivered and analyzed4.

The results deserve to be read slowly:

  • Semaglutide content exceeded the labeled amount by 28.56% to 38.69%. Not less than promised — more, which is its own dosing hazard.
  • Measured semaglutide purity ranged from 7.7% to 14.37%, against the 99% claimed on the labels4.
  • Endotoxin was detected in all samples, at 2.1645 to 8.9511 EU/mg, in material intended for injection4.

Hold those two purity figures side by side. If a vial is 7.7% to 14.37% pure and simultaneously over-labeled on content, the great majority of what is being injected is something other than the drug, and no party in the chain can say what.

That pattern is not confined to semaglutide. A systematic impurity-profiling study of the ten most frequently encountered falsified peptide drugs on the Belgian market, purchased from three suspected illegal internet pharmacies, found high variation in drug quantity per unit and purity ranging between 5% and 75% for cysteine-containing peptides — plus contamination with arsenic and lead, with multiple samples reaching concentrations up to ten times the international toxicity limit for parenteral drugs5. Injectable products, heavy metals, ten times the limit.

This is the concrete answer to "is a cheap vial really that different." It is measurably different, and the measurements have been published.

The dose arithmetic that gives false comfort

A specific failure mode is worth naming because it is so common. Someone reconstitutes a gray-market vial, works the concentration carefully, and concludes the dosing is precise.

The arithmetic is not the weak link. Converting a labeled mass and a volume of diluent into micrograms per syringe unit is exact, and our semaglutide reconstitution calculator, tirzepatide reconstitution calculator and general peptide calculator will do it to the decimal. The weak link is the input. Every one of those calculations starts from the number printed on the label, and the analyzes above found that number wrong by 28–39% in one direction while purity sat below 15%4. A precise answer computed from a false input is not precision; it is confidence in the wrong place. The technique itself is covered in how to reconstitute peptides, and the diluent has its own rules in our bacteriostatic water guide.

The side-effect profile that comes with the real drug

Even at tier one, these injections are not consequence-free, and the athletic corners of the internet tend to underplay it.

Gastrointestinal adverse events are the dominant tolerability issue. In STEP 1, nausea and diarrhea were the most common adverse events, and 4.5% of the semaglutide group discontinued treatment for gastrointestinal events versus 0.8% on placebo1. A state-of-the-art safety review notes that beyond the familiar nausea, vomiting, diarrhea and constipation of dose escalation, accumulating evidence has identified further gastrointestinal complications including cholelithiasis, cholecystitis, gastroparesis and bowel obstruction6. A cross-sectional analysis of a large research cohort likewise found an association between GLP-1 receptor agonist use and gastrointestinal adverse events7 — and it is worth being precise about what a cross-sectional association can and cannot establish, which is prevalence in a population rather than causation in an individual.

None of this makes these drugs bad medicines. It makes them medicines, which is exactly the frame the "peptide injection" marketing removes.

What about the non-incretin injectables?

The other injectables marketed for weight loss are a different evidentiary category altogether, and mostly a much weaker one.

The growth-hormone fragments — AOD-9604 and HGH fragment 176-191 — are the compounds sold most explicitly as fat-loss injections, and their human program did not deliver on the promise the mechanism implied; we lay that out in the AOD-9604 evidence review and the HGH fragment 176-191 review. Tesamorelin is a genuine approved drug with randomized visceral-fat reduction, but in a specific clinical population for a specific fat depot, which we cover in tesamorelin for athletes. The GH secretagogues are sold on a lipolysis rationale that has never converted into demonstrated fat loss in healthy training people — see peptides for fat loss. And if the underlying goal is losing fat without losing muscle, the body-composition evidence is its own subject, which we work through in peptides for weight loss and muscle gain.

For anyone drug-tested, most of this category is banned in tested sport, year-round, and a prescription does not change that. Our prohibited-substance checker gives a per-compound answer rather than a rule you have to apply yourself.

The decision this page is really about

If you have concluded that an incretin drug is appropriate for you, the meaningful choice is not which molecule — it is which tier you buy from, because the evidence and the risk both attach to the tier rather than the name.

The approved product carries the trial data and a manufacturing chain. A compounded prescription carries a licensed clinician and a licensed pharmacy, with the honest caveat that it is not an FDA-approved product and the trial results were not generated with it — and that a clean pricing page is not a regulatory record, as Direct Meds shows by publishing the plainest price mechanics on either of our rankings while carrying an FDA warning letter dated 2025-09-09 over its marketing of compounded semaglutide and tirzepatide. The unregulated vial carries a published record of sub-15% purity, over-labeled content and endotoxin in every sample tested4, and, in the wider falsified-peptide literature, heavy metals above parenteral toxicity limits5. A clean-looking compounded storefront can still hide the fine print that matters: FeelGood's refund policy states in capital letters that no refund is issued upon cancellation outside the first 72 hours, and HeliMeds prices its GLP-1/GIP combination by the week rather than the month, a framing that obscures rather than clarifies the real monthly cost. Jently displays no LegitScript certification anywhere on its site, and its own refund terms rule out any refund once a consultation is completed or a prescription is dispensed, a harder line than most storefronts on this list take. Nirwana Health's "LegitScript certified" claim fares no better — no verifiable seal was found anywhere in its sparse, client-rendered homepage, and NuBloom, by contrast, is led by a named, credentialed physician with 25+ years of experience, a rarer and more checkable form of trust signal. PlexusDx's Shopify storefront runs a genuinely low $129/mo microdose entry point behind a page that never displays its own brand's logo anywhere, and Trinity Meds prices flat regardless of dose while naming both its operating entity and its clinical partner up front. A flat program price still leaves room for a misleading headline: Heros Health advertises "from $119/mo," but the real starting price is $149, stepping up to $199/mo ongoing, confirmed live. And a brand's reputation can outlast the product it built it on: Hims quietly exited compounded semaglutide for new patients after a March 2026 Novo Nordisk settlement — a change its own site never narrates to a visitor comparing it against compounded competitors like these. Real pharmacy disclosure and real lock-in can sit side by side: Joi and Blokes names seven compounding pharmacies in its own Terms of Service, confirmed live, while that same document states all sales are final, including a current subscription period if you're later found ineligible mid-plan. And a headline price only means something if a provider's own pages agree on it: Layla's compounded semaglutide ongoing rate reads $199, $237, or $297/mo depending on which of three landing pages you enter through, confirmed live. A published price-by-term matrix is genuinely rare in this category: Lttl shows the full cost of every commitment length up front — $199/mo month-to-month down to $129/mo on a 12-month prepay — rather than a single ambiguous headline number. A named clinical entity is only useful if it actually shows up where it's supposed to: LunaRx's own site never mentions the medical group prior research had named, instead naming a different founder entirely. And a first-month figure isn't the whole story either: Medi-Weightloss's $99 compounded-semaglutide price is a first-month rate only — the site states plainly that ongoing pricing "varies by program and location" and is never published. "Cancel anytime" is a claim worth reading past: NiceRx frames its plans as no-commitment, but the same FAQ states all sales are final and a refund isn't guaranteed once the pharmacy has dispensed your medication. And a "starting at" price only tells part of the story when it's specific to one drug: Options Medical Weight Loss's $199 headline is the injectable-semaglutide rate — tirzepatide, offered on the same site, starts at $299 instead. A named pharmacy is checkable in a way a vague claim isn't: REMEVi names four separate compounding pharmacies right on its homepage, printed on the vial label itself, confirmed live. And upfront pricing is worth noting when it's genuinely upfront: Revel Health shows its per-product prices directly on the homepage, confirmed live, rather than gating them behind an intake quiz. A bundled device is a real differentiator, but the commitment terms still matter: Signos includes an FDA-cleared Stelo biosensor with its GLP-1 program, confirmed live, though early cancellation on the 3- or 6-month term can carry a fee with no proration. And a "$199/mo" figure means something different depending on how it's actually billed: SkyRx confirms, verbatim, that its $199/mo price requires a full 12-month subscription paid upfront. Naming a pharmacy is a genuine transparency signal in this category: TeleClinic names Rush Pharmacy outright as its sole compounding partner, confirmed live and independently verified as a real, accredited 503A facility. And a company can be transparent about pricing while staying opaque about who's actually prescribing: TelePeptide's own site states it "does not itself practice medicine" and discloses its contracted medical group's identity only "on request," confirmed live. A directory listing can go stale fast in this category: Rebody Health has fully exited GLP-1 medication entirely, confirmed live — its current catalog is peptides and NAD+, with zero mention of semaglutide or tirzepatide anywhere on the site. And a rare four-pharmacy disclosure doesn't guarantee every other claim holds up: Harmony Wellness Clinic names all four of its compounding pharmacies in full detail, confirmed live, though a previously claimed LegitScript certification couldn't be found anywhere on the current site. A membership fee is worth checking against what it actually buys: Roen Rx requires a separate $39-then-$135/mo membership that doesn't include your GLP-1 medication, confirmed live, on a platform that also received an FDA warning letter dated 2026-06-08. And a menu can genuinely differ across dosing formats: Fitish's separate microdosing tier prices lower than its standard 28-day supply, confirmed live, though no physical address or named pharmacy appears anywhere accessible. A product can be listed and priced without actually being purchasable: Tonik Wellness prices tirzepatide in full tiers, confirmed live, yet the drug doesn't appear anywhere in the site's shop catalog, and semaglutide shows as out of stock. And a combined-drug product is only as transparent as the dose it discloses: Tru2u's "GLP Squared" injection combines semaglutide and tirzepatide for $275 flat, confirmed live, without stating either drug's dose until after a consultation. Where a badge image is hosted is an observable fact, even though it says nothing about who the certification belongs to: Transparent Meds' LegitScript badge is served from LegitScript's own CDN rather than self-hosted, confirmed live. And pricing that looked gated wasn't actually gated: ARSYNL Rx displays its needle-free hypospray price openly, confirmed live, with no bot-verification wall in the way. A single dollar figure isn't much use when the site itself can't agree on it: Corsica Health's compounded semaglutide shows four different prices across its homepage, plans page, product landing page, and a promo code, confirmed live, ranging from roughly $83 to $249 a month for what's marketed as the same product. And a named pharmacy is a real disclosure even when the drug name itself is withheld: Elara MD names its compounding pharmacy, Strive Pharmacy in Gilbert, AZ, with a full address, confirmed live, yet its homepage, FAQ, and Terms of Use never once name semaglutide or tirzepatide by name. Some sites simply don't render anything to check: NuDay Rx's own site returns only an empty, client-rendered application shell on every fetch attempt, confirmed live — no price, no pharmacy, no policy text, beyond confirming it runs on the same CareValidate/careGLP platform as OnlyRx, while OnlyRx, that platform sibling, publishes four "starting at" prices but never a single ongoing or maintenance-dose figure anywhere reachable, confirmed live. And a clinical network is worth checking independently of the storefront quoting it: Remi Meds names its pharmacy, Strive Pharmacy in Gilbert, AZ, in full, confirmed live, while its clinical network, Beluga Health, is one of four medical groups a March 2026 STAT News investigation ties to a wider pattern of FDA-warned telehealth peers. A real convenience differentiator is still worth pricing carefully: WePeptideRx ships medication pre-mixed and ready to inject, skipping reconstitution entirely, confirmed live, though its compounding pharmacy is never individually named. And where a certification badge is hosted is worth noting, even though hosting alone does not show whose certification it is: Next Vial's LegitScript badge is served from LegitScript's own CDN with a published certificate ID rather than self-hosted, confirmed live. A linked trust page is worth clicking through, not just trusting: Avono Health's homepage testimonials link out to a Reviews.co.uk page that itself reads "we don't have reviews for Avono Health," confirmed live, even as it separately names two physicians and four compounding pharmacies on its own legal page. A well-known "cheap Ozempic" name isn't always what it seems: Cost Plus Drugs' own sitemap contains zero semaglutide or tirzepatide product URLs, confirmed live — its only GLP-1-adjacent product is generic liraglutide, priced at $791.25 for a five-pen box. And a once-refundable fee can quietly become free: Fitstry's one-time program fee, previously $99 and refundable, is now a promotional $0, confirmed live, while its previously undisclosed excluded state is now named plainly (Louisiana). A generic marketing claim is worth tracing to its actual source: Trimrose markets "lose up to 22.5% of your body weight," confirmed live, without disclosing that figure comes from branded tirzepatide's clinical trial, not necessarily its own compounded product. Tier names can stand in for a drug name a site never actually states: Joey Med sells "GLP-1 Core" and "GLP-1 Plus Core" tiers, confirmed live, with "semaglutide" and "tirzepatide" appearing only in hidden meta tags and coupon codes, never in visible page text. A blocked site is its own kind of finding, worth flagging rather than filling in: LIV by WellNow's live site returned an AWS WAF block on every fetch attempt this pass, so its pricing and disclosures here rest on an archived snapshot, not a direct confirmation. And a published certificate ID is worth naming when it's the exception, not the rule: Tryozi's LegitScript badge is served from LegitScript's own CDN with a published certificate ID rather than self-hosted, confirmed live. A coverage claim is only as good as the tool that's supposed to confirm it: VirtualCare2Go's own live service-area selector lists exactly one state, Texas, confirmed live, despite being commonly listed alongside nationwide providers. And a tirzepatide-only shop is worth knowing before you go looking for the other drug: Emerge Weight Loss markets, prices, and dispenses tirzepatide exclusively, confirmed live — semaglutide appears exactly once anywhere on the site, buried in Terms of Service boilerplate. A named medical team is a real signal even alongside an unresolved coverage question: Elevated Health names a Chief Medical Officer and a VP of Pharmacy Operations, confirmed live, though it also offers a genuine 30-day satisfaction guarantee limited to month-to-month plans only. A product name can promise more than the fine print backs up: Apex MD's "Compounded Semaglutide + NAD + B-12 + L-Carnitine" name implies a fixed blend, confirmed live, but its own footnote says the mix "may consist of one, two, or all three additives," provider's discretion. And a certification is worth confirming directly rather than assuming absent: Better U Care's homepage embeds a domain-specific LegitScript seal, confirmed live, alongside a real 34-jurisdiction coverage list that prior research had understated as 21 states. A famous brand isn't always the most transparent one: Henry Meds' own product pages never render a specific semaglutide or tirzepatide price anywhere, confirmed live — only a single "starts at $179/month" floor, with the real figure gated behind an interactive flow. A marketing claim and a binding legal document don't always agree: AskRx's homepage says "our own pharmacy" at least eight times, confirmed live, while its own Terms of Service state it operates no pharmacy at all and routes prescriptions to NovoCare or LillyDirect instead. A vague price and a strict guarantee can sit on the same page: Fella Health's core GLP-1 price is never published anywhere on the site, confirmed live — only a vague "under $10 per day" figure — though its 6-month money-back guarantee is genuinely detailed. And a policy page that renders empty is worth noticing before you sign anything: iThriveMD's Terms of Use and Return Policy pages contain zero occurrences of "refund" or "arbitration" in their fetchable content, confirmed live, despite a separately populated End User Agreement page on the same site. Named physicians are worth more than an anonymous provider pool, even without a public price: Lumora names two founding physicians, confirmed live, though its pricing for both semaglutide and tirzepatide is gated entirely behind the intake process. A price-lock promise is a real commitment: MyStart Health guarantees your rate "will never change," confirmed live, alongside a LegitScript seal carrying a published certificate ID. And a brand-only positioning is a real differentiator, even alongside a network worth knowing about: PrideRx prescribes only FDA-approved brand-name medication, confirmed live, though its own Terms of Service never name the operating legal entity anywhere in the document. A specific, quantified guarantee is worth more than a vague promise: Prime Health refunds four months of billing if you don't lose 10% of baseline weight in 16 weeks, confirmed live, though it runs on the same shared platform and clinical network as Remedy Meds. And a leaked line of code can confirm what marketing copy never says: Remedy Meds' own embedded page data contains a literal reference to "primeHealth," confirmed live, direct evidence it shares infrastructure with Prime Health. A certification badge is only useful on the page a reader actually lands on: tru Weight Loss's LegitScript seal appears on its homepage, confirmed live, but not on the dedicated pricing page most comparison-shoppers would check first. And a physician credential is checkable against the federal record itself: Dr. Arevitalize names two physicians whose NPI numbers were independently cross-checked against the CMS NPI Registry on this pass and confirmed real, active, and licensed. Real refill savings are worth less without the exact numbers behind them: TeleHealth Weight Solutions advertises refills dropping "as low as $60 per month" depending on vial size, confirmed live, though no specific per-vial-size price table is published anywhere on the site. A named pharmacy is a real disclosure, even on a site with pricing that won't settle down: ClickSlim names its pharmacy, DiRx Health, confirmed live, while its own homepage quotes four different prices for the same tirzepatide plan. And a full published pricing table is a real differentiator, even for a brand-only platform: Knownwell publishes a complete, dated price list across every branded GLP-1 option, confirmed live, correcting a prior finding that self-pay pricing wasn't posted. A public company's own investor materials are a source most storefronts can't offer: LifeMD's investor-relations site discloses 2.4 million virtual consults and 365,000 active patients, confirmed live, though no LegitScript certification was found anywhere on its own site. The manufacturer's own channel is a different animal from a telehealth storefront, and worth reading exactly: NovoCare Pharmacy, Novo Nordisk's own branded Wegovy program, excludes government-insured patients from its copay savings offer specifically, confirmed live, though those same patients can still use its self-pay pricing. And a broad menu is worth less when every price is invisible: Vital Edge lists both compounded and brand-name GLP-1 options, confirmed live, but every dollar figure loads from a backend at runtime, with nothing published statically. A hidden fee in a checkout flow is worth catching before you start, not after: Concierge MD LA's intake form discloses a $250 cancellation fee or a $650/month fallback plan if insurance doesn't cover a brand-name drug, confirmed live, disclosed nowhere in the headline pricing. A flat, all-doses price is worth more when the entity behind it is disclosed too: TeleCareSpot prices semaglutide and tirzepatide flat at every dose, confirmed live, though no legal entity is named anywhere on the site, not even its own Terms and Conditions. And a clear refund policy from a named entity is a real, checkable positive: TeleDocs360's two-stage refund structure is stated in plain language, confirmed live, from a named LLC with a real Memphis, TN address. A certification badge can be present and still easy to miss: WeightCare's LegitScript seal is embedded as a footer script rather than a visible badge image, confirmed live — the kind of disclosure a quick visual scan can overlook. A named pharmacy network is worth more than an anonymous supply chain: Kova discloses its pharmacy network, Telegra Pharmacy Network, and its prescriber by name, confirmed live, though it never states whether the injection itself is semaglutide or tirzepatide. A multi-pharmacy marketplace is a different model worth knowing about: Valhalla Vitality lets patients choose among several licensed partner pharmacies at one fixed price, confirmed live, though the specific drug and price stay gated behind a portal sign-up. Not every checkout page is attached to an actual medical review: Shape Vantage links its purchase button directly to a bare Stripe checkout, confirmed live, with no intake form or named prescriber found anywhere on the site. Free-consultation models are worth reading the fine print on: NowPatient charges nothing for its consultation and bills only for medication actually prescribed, confirmed live, though its live pricing renders only in British pounds rather than US dollars. Brand-name-only doesn't mean risk-free by default: myRocky dispenses only FDA-approved Ozempic, Mounjaro, and Wegovy with no compounded option, confirmed live, alongside a LegitScript seal. A cancel-anytime claim is worth reading against what actually backs it: Always Wellness and Recovery advertises no mandatory subscription and unlimited HIPAA-secure messaging, confirmed live, on a site whose claimed medical director's name this pass couldn't find anywhere in the code. A concierge injection program is a different model from a subscription funnel: Ambiante Health & Wellness bundles provider-directed dosing, secure messaging, and discreet direct delivery into one concierge plan, confirmed live, with a genuine refund if a prescription can't be verified. And a granular state-exclusion list is worth more than a vague coverage claim: Balanced Hormone Health discloses a distinct do-not-ship state list for each of its four compounding pharmacy partners, confirmed live, even though none of the four is individually named. A "not charged until approved" promise is worth knowing about before you commit to an injection program: Blue Haven RX doesn't charge you until a licensed physician approves your prescription, confirmed live, bundling consult, medication, and shipping into one flat fee. And naming your actual pharmacy partners is a real form of injection-specific transparency: Bodyshop Wellness discloses three specific, address-verified compounding pharmacies, confirmed live, alongside a LegitScript seal. A certification you can check on the certifier's own domain is worth more than a marketing claim: Calibrate Health carries both a domain-matched LegitScript seal and an independently verifiable Validation Institute badge, confirmed live, alongside a published multi-year outcomes report. And a program built around a specific life stage is a different pitch than a generic funnel: California Trim Clinic's Women's Microdosing program specifically targets perimenopause and menopause-related weight changes, confirmed live, backed by real, named-staff Google reviews. And a long track record is worth pairing with a named, checkable prescriber: Defy Medical's medical director independently checks out as real and active via the federal NPI registry, confirmed live, backed by comprehensive blood testing before any GLP-1 prescription. A broad peptide catalog is a different kind of offering than a single GLP-1 product: EmbraceRX's LegitScript seal and its partnership with the real Samaritan MD physician network sit alongside a much broader peptide and longevity menu than most single-drug competitors. And menopause-specific credentialing is a genuinely different angle than generic GLP-1 marketing: Evernow's named medical leadership and Menopause Society certified providers sit alongside a domain-matched LegitScript seal, confirmed live. And a verifiable academic credential is rare enough in this category to be worth naming: Gatlan's Chief Medical Advisor, Dr. Robert Lufkin, independently checks out as a real, active physician with a genuine USC Keck School of Medicine faculty appointment, confirmed live. A real legal entity is worth something even alongside other gaps: Hormonally Balanced discloses its legal entity, WHRT Services, LLC, confirmed live, alongside a domain-matched LegitScript seal. All-inclusive pricing with no separate membership fee is still uncommon enough to note: Kongo prices compounded semaglutide injections at $119/month and tirzepatide at $229/month, confirmed live, both bundling the provider visit, supplies, and shipping into one figure. Injectable GLP-1 access through an employer benefit looks different from a cash-pay storefront: Ilant Health's described care team includes a board-certified obesity provider, dietitians, and peer navigators, confirmed live, though no individual clinicians are named to check against the federal NPI registry. And a "starting at" price is a floor, not a full quote: Iron Med Rx advertises GLP-1 injections and oral tablets "starting at $149," confirmed live, with full dose-tier pricing only available after completing its intake. An NPI-verified nurse practitioner is real credibility, even alongside a pricing gap: JM Integrated Health's founder, John Meyer, FNP-C, independently checks out as active via the federal NPI registry, confirmed live, though no compounding pharmacy is named anywhere on the site. A GLP-1 injection's real cost depends entirely on who you're matched to: Klarity Health prices GLP-1 medication anywhere from $25 to $1,500 a month depending on insurance and pharmacy, confirmed live, since it's a marketplace of independent practices rather than one provider. And a brand-name-only platform is worth pricing carefully before assuming both drugs are quoted: Klinic states its Wegovy self-pay price at roughly $499/month, confirmed live, but no comparable figure for Zepbound appears anywhere on the live site. Named clinical partners are worth more than an anonymous pharmacy, even without an individual clinician attached: LovelyMeds names its pharmacy and prescribing partners directly, confirmed live, though neither entity could be found under those names in the federal NPI registry's organization search. And a platform's own copy can draw a real line most competitors blur: Maven Clinic's new consumer GLP-1 arm is explicitly labeled "Open Beta," confirmed live, with itemized self-pay pricing from $149 to over $1,000 a month depending on drug and delivery form. Discretion is a real limiter worth knowing before you book: MDLive's GLP-1 access runs through a Primary Care Routine Care visit, confirmed live, at the clinician's discretion — not guaranteed, and excluded in Florida, Louisiana, Mississippi, and New Jersey. And a genuinely permissive cancellation term is worth calling out directly: Meto's cancellation policy states plainly, confirmed live and verbatim, "No phone calls, no retention scripts" — an unusually permissive term in this category. A menopause-focused platform can still surprise on drug flexibility: Midi Health's own weight-management page states clinicians "can prescribe brand-name GLP-1s or compounded options if appropriate," confirmed live, refining a purely insurance-billed, branded-only assumption. And a credential worth double-checking is one you can't find in the registry at all: one of Mochi Health's four named physicians, listed with an FRCP(C) credential suggesting Canadian training, could not be matched to any US NPI record, confirmed on this pass. Transparent injectable pricing is worth noting when it's shown openly: Näky prices compounded tirzepatide openly on its product page, confirmed live — $295 for one month down to as low as $265/month on a 6-month plan, not gated behind intake. And a named pharmacy's coverage gaps are worth disclosing plainly: Nouri discloses that its named compounding pharmacy isn't licensed in 10 specific states, confirmed live, naming a second pharmacy that covers those exact gaps. A specifically named pharmacy list is real disclosure worth noticing: Nu Image Medical names its pharmacy partners specifically in its own Terms and Conditions, confirmed live — Absolute Pharmacy LLC, Belmar Pharma Solutions, The Pharmacy Hub, and Tailor Made Compounding. And a familiar brand name doesn't guarantee it's the one actually writing the prescription: Omada Health's core program carries no public consumer price anywhere, confirmed live — access runs entirely through an employer or health plan. A seal is worth noticing when it's implemented correctly: Omzo's LegitScript badge is served from LegitScript's own CDN and carries a correct, domain-matched checker link, confirmed live. And a named pharmacy partner with a full address is worth more than a generic claim: Refills names its pharmacy partner directly, confirmed live, on a dedicated page — Perfect Rx Pharmacy in Bartonville, TX, with a full address and contact email. A named pharmacy is real disclosure worth noticing alongside a coverage gap: RegenCen names its compounding pharmacy directly, confirmed live — Belmar Pharmacy in Golden, CO, refuting a prior hypothesis that none was disclosed. And two pricing tracks from the same practice are worth comparing before picking one: Rivas Medical Weight Loss's telehealth pricing track, confirmed live, is actually cheaper per month than its in-office pay-as-you-go weekly rate for the identical medications. A company's age is a checkable fact, not a vibe: Risen Labs' own Terms of Service disclose its operating LLC was formed May 11, 2026, confirmed live — roughly three months before this review, with no prior web-archive history. Named pharmacy partners are a real disclosure signal worth noticing: Rixa Health names three compounding pharmacy partners directly, confirmed live, on a dedicated page — a rare level of specificity in this category. And an insurance path alongside a self-pay one is a real choice worth comparing: Shapely accepts major PPO insurance and Medicare for brand-name GLP-1s at copay, confirmed live, alongside a separate self-pay compounded option. Named pharmacy partners deserve real disclosure, not just a badge: Tablet Health names four compounding pharmacy partners with full addresses, confirmed live — more specific disclosure than most competitors in this category. Employer scale is a real, checkable stat worth citing directly: Teladoc Health confirms real scale claims directly, confirmed live: "100+ U.S. health plans" and "50%+ Fortune 500 Employers" partner with the company. And a badge served from a third-party platform is a weaker signal than a live one: TeleSlim Clinic's LegitScript badge is self-hosted on a third-party practice-website platform's asset server, confirmed live, rather than served from LegitScript's own CDN. A specific compliance statement is worth more than a generic disclaimer: This Gen Wellness discloses, confirmed live and verbatim, that it does "not use AI to write prescriptions" — a specific compliance statement stronger than most competitors on this list. And a mail-forwarding address pattern is worth noticing even alongside otherwise-bold claims: Thriving Again's business address, confirmed live, follows a format consistent with a commercial LLC-formation mail-forwarding service, not a clinic. A named founder's own federal record is the cleanest verification available: The Virtual NP's founder has a federal NPI record whose registered state licenses match the site's own advertised 7-state coverage exactly, state for state, confirmed independently. A named pharmacy in the marketing copy is worth more than one buried in the fine print: TideMedix's compounding pharmacy is named, confirmed live in its Privacy Policy — TideMedix/Manifest Pharmacy in Bradenton, FL. And named pharmacy partners deserve to be seen where you'd actually look for them: UR Meds names three real pharmacy partners with full addresses, confirmed live — but only in its Terms of Use, never on the marketing pages that sell the product. Pricing consistency within a single page matters too: VigorMeds' own weight-management page shows two different prices for the identical medication and form — one set in the hero banner, a higher set in its own interactive quote-builder. Not every program is built to keep you on the injection long-term: Virta Health structures its program around clinically tapering members off GLP-1s and back onto nutrition therapy, confirmed live, rather than maximizing prescribing. And named pharmacy partners are worth checking against a directory's own hypothesis: VivioMD names four real compounding pharmacy partners with working links, confirmed live, refuting an earlier hypothesis that it didn't offer GLP-1 medications at all. A national retail pharmacy is worth knowing about too: Walgreens Weight Management prices Zepbound from $299/month and Wegovy from $149/month with a manufacturer savings card, confirmed live, though every medication is brand-name — no compounded option exists, and WeightWatchers Clinic names its fulfillment pharmacy directly — CenterWell Pharmacy — for at least one dose tier, confirmed live. And a directory's central hypothesis can simply be wrong: ZipHealth offers real, fully priced Zepbound and Wegovy product pages, confirmed live, directly refuting an earlier hypothesis that its GLP-1 offering was limited to compounded liraglutide alone.

Those are not three prices for one product. They are three different products, and only one of them was in the trial.

Leads our published comparison

CoreAge Rx

From $99/mo

Consult included, no commitment lever, no labs required, dietitian support — on the columns we can source.

If you are drug tested, read this first: These are banned in tested sport, at all times — and a prescription does not change that. Check the compound.

See CoreAge Rx pricing
Pricing
Not a flat rate
Pharmacy
Unnamed network
Labs
Not required

Advertising disclosure · both cards are paid partners and we may earn a commission at no extra cost to you — see our disclosure.

Also worth knowing

Live Vital

A deep recovery bench where every "/mo" price is a 10-week total divided by three — and BPC-157 has slipped off the index.

Pricing
Prepay required
Pharmacy
Unnamed network
Labs
Optional
See Live Vital

Frequently asked questions

Which peptide injections actually work for weight loss?

The incretin drugs are the only injectable peptides with large randomized human weight-loss evidence. Semaglutide produced a mean −14.9% body-weight change versus −2.4% on placebo over 68 weeks in STEP 1, and tirzepatide reached −20.9% at its highest dose over 72 weeks in SURMOUNT-1. Retatrutide reached −24.2% at 48 weeks in phase 2 but is not approved. The other injectables marketed for fat loss, particularly the growth-hormone fragments, have far weaker human evidence.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide and tirzepatide are not FDA-approved products. A licensed pharmacy prepares them against a prescription, so there is a real prescriber and pharmacy in the chain, but the preparation has not been through FDA review of its safety, efficacy or manufacturing, and the published trial results were generated with the approved product rather than with a compounded version.

What did testing find in weight-loss peptide vials bought online?

A 2024 market-surveillance study made test purchases from illegal online pharmacies selling semaglutide without prescription. Three of six orders never arrived. In the three vials delivered, semaglutide content exceeded the labeled amount by 28.56% to 38.69%, measured purity was 7.7% to 14.37% against 99% claimed on the label, and endotoxin was detected in every sample. A separate study of falsified peptide drugs found purity between 5% and 75% and arsenic and lead contamination, with several samples reaching up to ten times the toxicity limit for injectable drugs.

Does a reconstitution calculator make gray-market dosing safe?

No, and the reason is worth understanding. The arithmetic a calculator performs is exact: it converts a labeled mass and a volume of diluent into micrograms per syringe unit. But every such calculation starts from the number printed on the label, and analyzes of unregulated vials found that number wrong by 28 to 39% while purity sat below 15%. A precise result computed from an unverified input is confidence, not accuracy.

What are the side effects of weight-loss peptide injections?

Gastrointestinal effects dominate. In STEP 1, nausea and diarrhea were the most common adverse events and 4.5% of the semaglutide group discontinued for gastrointestinal events versus 0.8% on placebo. A recent safety review notes that beyond the nausea and vomiting of dose escalation, accumulating evidence has identified cholelithiasis, cholecystitis, gastroparesis and bowel obstruction as further gastrointestinal complications warranting caution.

References

  1. Wilding JPH, Batterham RL, Calanna S, Davies M, et al. (STEP 1 Study Group) (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, et al. (SURMOUNT-1 Investigators) (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. Jastreboff AM, Kaplan LM, Frías JP, Wu Q, et al. (2023). Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/37366315/
  4. Ashraf AR, Mackey TK, Vida RG, Kulcsár G, et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.. Journal of Medical Internet Research. https://pubmed.ncbi.nlm.nih.gov/39509151/
  5. Janvier S, Cheyns K, Canfyn M, Goscinny S, et al. (2018). Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market.. Talanta. https://pubmed.ncbi.nlm.nih.gov/30029448/
  6. Kunutsor SK, Seidu S (2026). Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review.. Drugs. https://pubmed.ncbi.nlm.nih.gov/41351656/
  7. Aldhaleei WA, Abegaz TM, Bhagavathula AS (2024). Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort.. Pharmaceuticals (Basel). https://pubmed.ncbi.nlm.nih.gov/38399414/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.